sarcoma - Articles and news items

FDA grants Priority Review for olaratumab BLA

Industry news / 4 May 2016 / Victoria White, Digital Content Producer

Lilly’s biologics license application is for olaratumab in combination with doxorubicin for the treatment of people with advanced soft tissue sarcoma…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+